Venkata Narayana Active Ingredients Profile
Key Indicators
- Authorised Capital ₹ 39.00 Cr
- Paid Up Capital ₹ 26.53 Cr
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 250.08 Cr
- Satisfied Charges ₹ 77.51 Cr
- Revenue Growth -18.55%
- Profit Growth 16.28%
- Ebitda 80.03%
- Net Worth -79.80%
- Total Assets -5.24%
About Venkata Narayana Active Ingredients
Venkata Narayana Active Ingredients Private Limited (VNAIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 September 2005 and has a history of 19 years and five months. Its registered office is in Chennai, Tamil Nadu, India.
The Corporate was formerly known as Venkatanarayana Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 39.00 Cr and a paid-up capital of Rs 26.53 Cr.
The company currently has active open charges totaling ₹250.08 Cr. The company has closed loans amounting to ₹77.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Venkata Narayana Active Ingredients Private Limited India are Ramesh Joijode as COMPANY SECRETARY and Thiruvengadathan Parthasarathi as Cfo. Chandra Verma, Deepak Abhayakumar, and Abhaya Srisrimal serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231TN2005PTC057504
- Company No.
057504
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Sep 2005
- Date of AGM
20 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Venkata Narayana Active Ingredients Private Limited offer?
Venkata Narayana Active Ingredients Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API (Active Pharmaceutical Ingredients), Blood System and Cardiovascular API, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs.
Who are the key members and board of directors at Venkata Narayana Active Ingredients?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh Joijode | Company Secretary | 27-Mar-2017 | Current |
Thiruvengadathan Parthasarathi  | CFO | 13-Sep-2021 | Current |
| Chandra Verma | Managing Director | 07-Dec-2022 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhaya Srisrimal | Director | 15-Sep-2005 | Current |
| Deepak Abhayakumar | Whole-Time Director | 12-Sep-2021 | Current |
Financial Performance of Venkata Narayana Active Ingredients.
Venkata Narayana Active Ingredients Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.55% decrease. The company also saw a substantial improvement in profitability, with a 16.28% increase in profit. The company's net worth observed a substantial decline by a decrease of 79.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Venkata Narayana Active Ingredients?
In 2023, Venkata Narayana Active Ingredients had a promoter holding of 84.71% and a public holding of 15.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shasunmed Life-Sciences Private LimitedAbhaya Srisrimal is a mutual person
H S Pathology Private LimitedDeepak Abhayakumar is a mutual person
General Optics (Asia) LtdAbhaya Srisrimal is a mutual person
Dhanvantari Nano Ayushadi Private LimitedDeepak Abhayakumar and Abhaya Srisrimal are mutual person
Cellutions Biostorage Private LimitedDeepak Abhayakumar is a mutual person
- Lifecell International Private Limited
Deepak Abhayakumar is a mutual person
Charges (Loans)
₹250.08 Cr
₹77.51 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 86.31 Cr
- Canara Bank : 83.82 Cr
- Hdfc Bank Limited : 79.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Mar 2023 | Hdfc Bank Limited | ₹10.00 Cr | Open |
| 09 Jan 2023 | Canara Bank | ₹0.98 M | Open |
| 07 Nov 2022 | Canara Bank | ₹1.21 M | Open |
| 07 Sep 2022 | Canara Bank | ₹3.43 M | Open |
| 03 Jul 2021 | Hdfc Bank Limited | ₹1.32 M | Open |
How Many Employees Work at Venkata Narayana Active Ingredients?
Venkata Narayana Active Ingredients has a workforce of 378 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venkata Narayana Active Ingredients, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venkata Narayana Active Ingredients's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
